EKF Diagnostics is a global medical diagnostics business with specialisms in point-of-care testing, central laboratory tests, enzyme manufacturing and the provision of contract manufacturing services to the healthcare industry.
EKF is listed on the London Stock Exchange's AIM market.
EKF's Point-of-Care heritage dates back to the development of glucose sensor technology in the 1990s. Since then our portfolio has broadened to include lactate, HbA1c and ketone testing.
EKF Diagnostics is also a manufacturer of Central Laboratory products including Stanbio Chemistry reagents, benchtop analyzers, rapid tests and centrifuges. Our chemistry reagents can be used on the majority of analyzers found in hospital laboratories around the world.
EKF Life Sciences has a long and successful reputation for delivering enzymes and contracted bio-products. The recently expanded production capacity at our manufacturing sites in the USA provides EKF Life Sciences with facilities to suit long-standing, high volume enzyme customers, as well as provide the flexibility needed for start-ups looking for tailored solutions.
Location: United Kingdom, Wales, Penarth
Employees: 201-500
Phone: +44 29 2071 0570
Founded date: 1990
Investors 1
| Date | Name | Website |
| - | H2O Ventur... | h2ovp.com |
Mentions in press and media 18
| Date | Title | Description | Source |
| 31.01.2022 | EKF Diagnostics : Non-executive Directorate Change | EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces the appoin... | marketscre... |
| 23.11.2021 | EKF Diagnostics : Directorate Change | EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces the appoin... | marketscre... |
| 11.11.2021 | EKF Diagnostics acquires ADL Health molecular diagnostic tes... | EKF Diagnostics, the global in vitro diagnostics company, announces that it has acquired Advanced Di... | marketscre... |
| 08.11.2021 | Director/PDMR Shareholding | EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces that it ha... | marketscre... |
| 26.10.2021 | Dividend confirmation | EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces that the B... | marketscre... |
| 12.10.2021 | EKF Diagnostics : Completion of acquisition, Admission &... | Capitalised terms in this announcement carry the same meaning as in the RNS of 28 September 2021, un... | marketscre... |
| 05.10.2021 | EKF Diagnostics : PDMR/ PCA Dealings | EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces that the B... | marketscre... |
| 28.09.2021 | EKF Diagnostics : Acquisition of US based Advanced Diagnosti... | All-share initial payment for earnings enhancing, cash generative acquisition New testing capacity c... | marketscre... |
| 15.09.2021 | EKF Diagnostics : to showcase new handheld β-ketone and gluc... | First live viewing of EKF's STAT-Site® WB analyzer for reliable and efficient dual analyte measureme... | marketscre... |
| 16.06.2021 | EKF DIAGNOSTICS HOLDINGS PLC EKF Diagnostics : Change of Ad... | EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed point-of-care business, announces the appoin... | marketscre... |
Show more